课题基金 / 基金详情

Copper Drug Complexes: Development of a novel class of drugs with significant potential for treatment of platinum insensitive cancers

Copper Drug Complexes: Development of a novel class of drugs with significant potential for treatment of platinum insensitive cancers
铜药物复合物：开发一类新型药物，具有治疗铂不敏感癌症的巨大潜力
批准号：
357858
负责人：
Bally Marcel B
金额：
$35.67万
依托单位：
BC Cancer, part of PHSA (Vancouver)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-10-01 至 2020-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=357858&lang=en
关键词：
Anticancer Drugs Copper Drug Development Formulation Development Liposomes Metal Complexes Pharmacodynamics Pharmacokinetics Platinum Insensitive Repurposing

项目摘要

项目成果

Bally Marcel B的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
One strategy that Dr. Bally has been using to develop drug candidates for use in treating cancer involves repurposing drugs utilized for the treatment of diseases other than cancer; illnesses such as malaria, fungal infections or even alcoholism. He wants
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金